Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar;19(1):49-51.
doi: 10.5114/kitp.2022.114557. Epub 2022 Mar 24.

Ibrutinib-associated alveolar hemorrhage and spontaneous hemothorax

Ismail Tombul  1 , Muhammet Sayan  1 , Nazlihan Boyaci Dundar  2 , Asena Dikyar  3 , Seyma Yildiz  3 , Ali Celik  1
Affiliations

Ibrutinib-associated alveolar hemorrhage and spontaneous hemothorax

Ismail Tombul et al. Kardiochir Torakochirurgia Pol. 2022 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors report no conflict of interest.

Figures

Figure 1
Figure 1
A – Sinus bluntness is seen on the right chest X-ray. B – Thorax computed tomography shows alveolar hemorrhage and pleural effusion
Figure 2
Figure 2
A – Appearance of pleural fluid drained by catheter thoracostomy. B – Chest X-ray shows lung expansion after the catheter thoracostomy treatment
See this image and copyright information in PMC

References

    1. Shatzel JJ, Olson SR, Tao DL, McCarty OJT, Danilov AV, DeLoughery TG. Ibrutinib-associated bleeding: pathogenesis, management and risk reduction strategies. J Thromb Haemost. 2017;15:835–47. - PMC - PubMed
    1. Lipsky AH, Farooqui MZ, Tian X, Martyr S, Cullinane AM, Nghiem K, Sun C, Valdez J, Niemann CU, Herman SEM, Saba N, Soto S, Marti G, Uzel G, Holland SM, Lozier JN, Wiestner A. Incidence and risk factors of bleeding-related adverse events in patients with chronic lymphocytic leukemia treated with ibrutinib. Haematologica. 2015;100:1571–8. - PMC - PubMed
    1. Levade M, David E, Garcia C, Laurent PA, Cadot S, Michallet AS, Bordet JC, Tam C, Sié P, Ysebaert L, Payrastre B. Ibrutinib treatment affects collagen and von Willebrand factor-dependent platelet functions. Blood. 2014;124:3991–5. - PubMed
    1. Lehr A., Condos R. Spontaneous hemothorax in a patient on ibrutinib. Am J Respir Crit Care Med. 2020;201:A3124.
    1. von Hundelshausen P, Siess W. Bleeding by bruton tyrosine kinase-inhibitors: dependency on drug type and disease. Cancers. 2021;13:1103. - PMC - PubMed